Suppression of Non-small Cell Lung Tumor Development by the Let-7 MicroRNA Family

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2008 Mar 1

PMID 18308936

Citations 442

Authors

Madhu S Kumar

Stefan J Erkeland

Ryan E Pester

Cindy Y Chen

Margaret S Ebert

Phillip A Sharp

Tyler Jacks

Affiliations

Soon will be listed here.

Abstract

Many microRNAs (miRNAs) target mRNAs involved in processes aberrant in tumorigenesis, such as proliferation, survival, and differentiation. In particular, the let-7 miRNA family has been proposed to function in tumor suppression, because reduced expression of let-7 family members is common in non-small cell lung cancer (NSCLC). Here, we show that let-7 functionally inhibits non-small cell tumor development. Ectopic expression of let-7g in K-Ras(G12D)-expressing murine lung cancer cells induced both cell cycle arrest and cell death. In tumor xenografts, we observed significant growth reduction of both murine and human non-small cell lung tumors when overexpression of let-7g was induced from lentiviral vectors. In let-7g expressing tumors, reductions in Ras family and HMGA2 protein levels were detected. Importantly, let-7g-mediated tumor suppression was more potent in lung cancer cell lines harboring oncogenic K-Ras mutations than in lines with other mutations. Ectopic expression of K-Ras(G12D) largely rescued let-7g mediated tumor suppression, whereas ectopic expression of HMGA2 was less effective. Finally, in an autochthonous model of NSCLC in the mouse, let-7g expression substantially reduced lung tumor burden.

Citing Articles

MicroRNAs in lung cancer: their role in tumor progression, biomarkers, diagnostic, prognostic, and therapeutic relevance.

Chatterjee M, Nag S, Gupta S, Mukherjee T, Shankar P, Parashar D Discov Oncol. 2025; 16(1):293.

PMID: 40067551 PMC: 11896959. DOI: 10.1007/s12672-025-02054-9.

MicroRNA Gets a Mighty Award.

Li Y, Chen S, Rao H, Cui S, Chen G Adv Sci (Weinh). 2025; 12(7):e2414625.

PMID: 39836690 PMC: 11831481. DOI: 10.1002/advs.202414625.

MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration-Where Are We Now?.

Ferreira M, Morais M, Medeiros R, Teixeira A Pharmaceutics. 2024; 16(11).

PMID: 39598472 PMC: 11597238. DOI: 10.3390/pharmaceutics16111347.

The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses.

Liu W, Wu Y, Zhang T, Sun X, Guo D, Yang Z RNA Biol. 2024; 21(1):52-69.

PMID: 39449182 PMC: 11520539. DOI: 10.1080/15476286.2024.2414156.

Profile of miRNA expression in the hippocampus of epileptic mice and the prediction of potential therapeutic targets.

Tan Y, Yu Y, Niu H, Wang C, Mo P, Li D Mol Biol Rep. 2024; 51(1):929.

PMID: 39172288 DOI: 10.1007/s11033-024-09861-3.

References

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A . RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-47. DOI: 10.1016/j.cell.2005.01.014. View

Pasquinelli A, Reinhart B, Slack F, Martindale M, Kuroda M, Maller B . Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000; 408(6808):86-9. DOI: 10.1038/35040556. View

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H . Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004; 64(11):3753-6. DOI: 10.1158/0008-5472.CAN-04-0637. View

Valencia-Sanchez M, Liu J, Hannon G, Parker R . Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006; 20(5):515-24. DOI: 10.1101/gad.1399806. View

Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A . High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer. 2003; 39(2):167-9. DOI: 10.1002/gcc.10316. View

He L, He X, Lim L, de Stanchina E, Xuan Z, Liang Y . A microRNA component of the p53 tumour suppressor network. Nature. 2007; 447(7148):1130-4. PMC: 4590999. DOI: 10.1038/nature05939. View

Sevignani C, Calin G, Nnadi S, Shimizu M, Davuluri R, Hyslop T . MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A. 2007; 104(19):8017-22. PMC: 1876564. DOI: 10.1073/pnas.0702177104. View

10.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

11.

Jackson E, Olive K, Tuveson D, Bronson R, Crowley D, Brown M . The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res. 2005; 65(22):10280-8. DOI: 10.1158/0008-5472.CAN-05-2193. View

12.

Wang T, Zhang X, Obijuru L, Laser J, Aris V, Lee P . A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 2007; 46(4):336-47. DOI: 10.1002/gcc.20415. View

13.

Voorhoeve P, le Sage C, Schrier M, Gillis A, Stoop H, Nagel R . A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006; 124(6):1169-81. DOI: 10.1016/j.cell.2006.02.037. View

14.

Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C . let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007; 131(6):1109-23. DOI: 10.1016/j.cell.2007.10.054. View

15.

Reinhart B, Slack F, Basson M, Pasquinelli A, Bettinger J, Rougvie A . The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403(6772):901-6. DOI: 10.1038/35002607. View

16.

Psarras S, Karagianni N, Kellendonk C, Tronche F, Cosset F, Stocking C . Gene transfer and genetic modification of embryonic stem cells by Cre- and Cre-PR-expressing MESV-based retroviral vectors. J Gene Med. 2004; 6(1):32-42. DOI: 10.1002/jgm.442. View

17.

Mayr C, Hemann M, Bartel D . Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 2007; 315(5818):1576-9. PMC: 2556962. DOI: 10.1126/science.1137999. View

18.

Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S . Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101(9):2999-3004. PMC: 365734. DOI: 10.1073/pnas.0307323101. View

19.

Hebert C, Norris K, Scheper M, Nikitakis N, Sauk J . High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer. 2007; 6:5. PMC: 1783857. DOI: 10.1186/1476-4598-6-5. View

20.

Young A, Narita M . Oncogenic HMGA2: short or small?. Genes Dev. 2007; 21(9):1005-9. DOI: 10.1101/gad.1554707. View